Parkinsons Disease Drugs Market, Global Outlook and Forecast 2022-2028
Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.The symptoms generally come on slowly over time.Early in the disease, the most obvious are shaking, rigidity, slowness of movement, and difficulty with walking.Thinking and behavioral problems may also occur.Dementia becomes common in the advanced stages of the disease.Depression and anxiety are also common, occurring in more than a third of people with PD.Other symptoms include sensory, sleep, and emotional problems.The main motor symptoms are collectively called 'parkinsonism', or a 'parkinsonian syndrome'
This report contains market size and forecasts of Parkinsons Disease Drugs in global, including the following market information:
Global Parkinsons Disease Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Parkinsons Disease Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Parkinsons Disease Drugs companies in 2021 (%)
The global Parkinsons Disease Drugs market was valued at 5651 million in 2021 and is projected to reach US$ 8374.4 million by 2028, at a CAGR of 5.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Clinical Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Parkinsons Disease Drugs include Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma, Sigma-Tau Group, Fudan-Zhangjiang, Teva Pharmaceutical and CSPC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Parkinsons Disease Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Parkinsons Disease Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Parkinsons Disease Drugs Market Segment Percentages, by Type, 2021 (%)
Global Parkinsons Disease Drugs Market Segment Percentages, by Application, 2021 (%)
Global Parkinsons Disease Drugs Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Parkinsons Disease Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Parkinsons Disease Drugs revenues share in global market, 2021 (%)
Key companies Parkinsons Disease Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Parkinsons Disease Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Parkinsons Disease Drugs in global, including the following market information:
Global Parkinsons Disease Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Parkinsons Disease Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Parkinsons Disease Drugs companies in 2021 (%)
The global Parkinsons Disease Drugs market was valued at 5651 million in 2021 and is projected to reach US$ 8374.4 million by 2028, at a CAGR of 5.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Clinical Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Parkinsons Disease Drugs include Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma, Sigma-Tau Group, Fudan-Zhangjiang, Teva Pharmaceutical and CSPC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Parkinsons Disease Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Parkinsons Disease Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Parkinsons Disease Drugs Market Segment Percentages, by Type, 2021 (%)
- Clinical
- Experiment
Global Parkinsons Disease Drugs Market Segment Percentages, by Application, 2021 (%)
- Treament
- Prevention
Global Parkinsons Disease Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Parkinsons Disease Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Parkinsons Disease Drugs revenues share in global market, 2021 (%)
Key companies Parkinsons Disease Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Parkinsons Disease Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Johnson & Johnson
- Gilead Sciences
- Pacira
- Sun Pharmaceutical
- Luye Pharma
- Sigma-Tau Group
- Fudan-Zhangjiang
- Teva Pharmaceutical
- CSPC
- Novartis
- Kingond Pharm
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Parkinsons Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Parkinsons Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PARKINSONS DISEASE DRUGS OVERALL MARKET SIZE
2.1 Global Parkinsons Disease Drugs Market Size: 2021 VS 2028
2.2 Global Parkinsons Disease Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Parkinsons Disease Drugs Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Parkinsons Disease Drugs Players in Global Market
3.2 Top Global Parkinsons Disease Drugs Companies Ranked by Revenue
3.3 Global Parkinsons Disease Drugs Revenue by Companies
3.4 Global Parkinsons Disease Drugs Sales by Companies
3.5 Global Parkinsons Disease Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Parkinsons Disease Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Parkinsons Disease Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Parkinsons Disease Drugs Players in Global Market
3.8.1 List of Global Tier 1 Parkinsons Disease Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Parkinsons Disease Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Parkinsons Disease Drugs Market Size Markets, 2021 & 2028
4.1.2 Clinical
4.1.3 Experiment
4.2 By Type - Global Parkinsons Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Parkinsons Disease Drugs Revenue, 2017-2022
4.2.2 By Type - Global Parkinsons Disease Drugs Revenue, 2023-2028
4.2.3 By Type - Global Parkinsons Disease Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Parkinsons Disease Drugs Sales & Forecasts
4.3.1 By Type - Global Parkinsons Disease Drugs Sales, 2017-2022
4.3.2 By Type - Global Parkinsons Disease Drugs Sales, 2023-2028
4.3.3 By Type - Global Parkinsons Disease Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Parkinsons Disease Drugs Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Parkinsons Disease Drugs Market Size, 2021 & 2028
5.1.2 Treament
5.1.3 Prevention
5.2 By Application - Global Parkinsons Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Parkinsons Disease Drugs Revenue, 2017-2022
5.2.2 By Application - Global Parkinsons Disease Drugs Revenue, 2023-2028
5.2.3 By Application - Global Parkinsons Disease Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Parkinsons Disease Drugs Sales & Forecasts
5.3.1 By Application - Global Parkinsons Disease Drugs Sales, 2017-2022
5.3.2 By Application - Global Parkinsons Disease Drugs Sales, 2023-2028
5.3.3 By Application - Global Parkinsons Disease Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Parkinsons Disease Drugs Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Parkinsons Disease Drugs Market Size, 2021 & 2028
6.2 By Region - Global Parkinsons Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Parkinsons Disease Drugs Revenue, 2017-2022
6.2.2 By Region - Global Parkinsons Disease Drugs Revenue, 2023-2028
6.2.3 By Region - Global Parkinsons Disease Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Parkinsons Disease Drugs Sales & Forecasts
6.3.1 By Region - Global Parkinsons Disease Drugs Sales, 2017-2022
6.3.2 By Region - Global Parkinsons Disease Drugs Sales, 2023-2028
6.3.3 By Region - Global Parkinsons Disease Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Parkinsons Disease Drugs Revenue, 2017-2028
6.4.2 By Country - North America Parkinsons Disease Drugs Sales, 2017-2028
6.4.3 US Parkinsons Disease Drugs Market Size, 2017-2028
6.4.4 Canada Parkinsons Disease Drugs Market Size, 2017-2028
6.4.5 Mexico Parkinsons Disease Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Parkinsons Disease Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Parkinsons Disease Drugs Sales, 2017-2028
6.5.3 Germany Parkinsons Disease Drugs Market Size, 2017-2028
6.5.4 France Parkinsons Disease Drugs Market Size, 2017-2028
6.5.5 U.K. Parkinsons Disease Drugs Market Size, 2017-2028
6.5.6 Italy Parkinsons Disease Drugs Market Size, 2017-2028
6.5.7 Russia Parkinsons Disease Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Parkinsons Disease Drugs Market Size, 2017-2028
6.5.9 Benelux Parkinsons Disease Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Parkinsons Disease Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Parkinsons Disease Drugs Sales, 2017-2028
6.6.3 China Parkinsons Disease Drugs Market Size, 2017-2028
6.6.4 Japan Parkinsons Disease Drugs Market Size, 2017-2028
6.6.5 South Korea Parkinsons Disease Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Parkinsons Disease Drugs Market Size, 2017-2028
6.6.7 India Parkinsons Disease Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Parkinsons Disease Drugs Revenue, 2017-2028
6.7.2 By Country - South America Parkinsons Disease Drugs Sales, 2017-2028
6.7.3 Brazil Parkinsons Disease Drugs Market Size, 2017-2028
6.7.4 Argentina Parkinsons Disease Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Parkinsons Disease Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Parkinsons Disease Drugs Sales, 2017-2028
6.8.3 Turkey Parkinsons Disease Drugs Market Size, 2017-2028
6.8.4 Israel Parkinsons Disease Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Parkinsons Disease Drugs Market Size, 2017-2028
6.8.6 UAE Parkinsons Disease Drugs Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Parkinsons Disease Drugs Major Product Offerings
7.1.4 Johnson & Johnson Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Johnson & Johnson Key News
7.2 Gilead Sciences
7.2.1 Gilead Sciences Corporate Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Parkinsons Disease Drugs Major Product Offerings
7.2.4 Gilead Sciences Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Gilead Sciences Key News
7.3 Pacira
7.3.1 Pacira Corporate Summary
7.3.2 Pacira Business Overview
7.3.3 Pacira Parkinsons Disease Drugs Major Product Offerings
7.3.4 Pacira Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Pacira Key News
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Corporate Summary
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Parkinsons Disease Drugs Major Product Offerings
7.4.4 Sun Pharmaceutical Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Sun Pharmaceutical Key News
7.5 Luye Pharma
7.5.1 Luye Pharma Corporate Summary
7.5.2 Luye Pharma Business Overview
7.5.3 Luye Pharma Parkinsons Disease Drugs Major Product Offerings
7.5.4 Luye Pharma Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Luye Pharma Key News
7.6 Sigma-Tau Group
7.6.1 Sigma-Tau Group Corporate Summary
7.6.2 Sigma-Tau Group Business Overview
7.6.3 Sigma-Tau Group Parkinsons Disease Drugs Major Product Offerings
7.6.4 Sigma-Tau Group Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Sigma-Tau Group Key News
7.7 Fudan-Zhangjiang
7.7.1 Fudan-Zhangjiang Corporate Summary
7.7.2 Fudan-Zhangjiang Business Overview
7.7.3 Fudan-Zhangjiang Parkinsons Disease Drugs Major Product Offerings
7.7.4 Fudan-Zhangjiang Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Fudan-Zhangjiang Key News
7.8 Teva Pharmaceutical
7.8.1 Teva Pharmaceutical Corporate Summary
7.8.2 Teva Pharmaceutical Business Overview
7.8.3 Teva Pharmaceutical Parkinsons Disease Drugs Major Product Offerings
7.8.4 Teva Pharmaceutical Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Teva Pharmaceutical Key News
7.9 CSPC
7.9.1 CSPC Corporate Summary
7.9.2 CSPC Business Overview
7.9.3 CSPC Parkinsons Disease Drugs Major Product Offerings
7.9.4 CSPC Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.9.5 CSPC Key News
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Parkinsons Disease Drugs Major Product Offerings
7.10.4 Novartis Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Novartis Key News
7.11 Kingond Pharm
7.11.1 Kingond Pharm Corporate Summary
7.11.2 Kingond Pharm Parkinsons Disease Drugs Business Overview
7.11.3 Kingond Pharm Parkinsons Disease Drugs Major Product Offerings
7.11.4 Kingond Pharm Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Kingond Pharm Key News
8 GLOBAL PARKINSONS DISEASE DRUGS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Parkinsons Disease Drugs Production Capacity, 2017-2028
8.2 Parkinsons Disease Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Parkinsons Disease Drugs Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PARKINSONS DISEASE DRUGS SUPPLY CHAIN ANALYSIS
10.1 Parkinsons Disease Drugs Industry Value Chain
10.2 Parkinsons Disease Drugs Upstream Market
10.3 Parkinsons Disease Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Parkinsons Disease Drugs Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Parkinsons Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Parkinsons Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PARKINSONS DISEASE DRUGS OVERALL MARKET SIZE
2.1 Global Parkinsons Disease Drugs Market Size: 2021 VS 2028
2.2 Global Parkinsons Disease Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Parkinsons Disease Drugs Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Parkinsons Disease Drugs Players in Global Market
3.2 Top Global Parkinsons Disease Drugs Companies Ranked by Revenue
3.3 Global Parkinsons Disease Drugs Revenue by Companies
3.4 Global Parkinsons Disease Drugs Sales by Companies
3.5 Global Parkinsons Disease Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Parkinsons Disease Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Parkinsons Disease Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Parkinsons Disease Drugs Players in Global Market
3.8.1 List of Global Tier 1 Parkinsons Disease Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Parkinsons Disease Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Parkinsons Disease Drugs Market Size Markets, 2021 & 2028
4.1.2 Clinical
4.1.3 Experiment
4.2 By Type - Global Parkinsons Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Parkinsons Disease Drugs Revenue, 2017-2022
4.2.2 By Type - Global Parkinsons Disease Drugs Revenue, 2023-2028
4.2.3 By Type - Global Parkinsons Disease Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Parkinsons Disease Drugs Sales & Forecasts
4.3.1 By Type - Global Parkinsons Disease Drugs Sales, 2017-2022
4.3.2 By Type - Global Parkinsons Disease Drugs Sales, 2023-2028
4.3.3 By Type - Global Parkinsons Disease Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Parkinsons Disease Drugs Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Parkinsons Disease Drugs Market Size, 2021 & 2028
5.1.2 Treament
5.1.3 Prevention
5.2 By Application - Global Parkinsons Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Parkinsons Disease Drugs Revenue, 2017-2022
5.2.2 By Application - Global Parkinsons Disease Drugs Revenue, 2023-2028
5.2.3 By Application - Global Parkinsons Disease Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Parkinsons Disease Drugs Sales & Forecasts
5.3.1 By Application - Global Parkinsons Disease Drugs Sales, 2017-2022
5.3.2 By Application - Global Parkinsons Disease Drugs Sales, 2023-2028
5.3.3 By Application - Global Parkinsons Disease Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Parkinsons Disease Drugs Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Parkinsons Disease Drugs Market Size, 2021 & 2028
6.2 By Region - Global Parkinsons Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Parkinsons Disease Drugs Revenue, 2017-2022
6.2.2 By Region - Global Parkinsons Disease Drugs Revenue, 2023-2028
6.2.3 By Region - Global Parkinsons Disease Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Parkinsons Disease Drugs Sales & Forecasts
6.3.1 By Region - Global Parkinsons Disease Drugs Sales, 2017-2022
6.3.2 By Region - Global Parkinsons Disease Drugs Sales, 2023-2028
6.3.3 By Region - Global Parkinsons Disease Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Parkinsons Disease Drugs Revenue, 2017-2028
6.4.2 By Country - North America Parkinsons Disease Drugs Sales, 2017-2028
6.4.3 US Parkinsons Disease Drugs Market Size, 2017-2028
6.4.4 Canada Parkinsons Disease Drugs Market Size, 2017-2028
6.4.5 Mexico Parkinsons Disease Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Parkinsons Disease Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Parkinsons Disease Drugs Sales, 2017-2028
6.5.3 Germany Parkinsons Disease Drugs Market Size, 2017-2028
6.5.4 France Parkinsons Disease Drugs Market Size, 2017-2028
6.5.5 U.K. Parkinsons Disease Drugs Market Size, 2017-2028
6.5.6 Italy Parkinsons Disease Drugs Market Size, 2017-2028
6.5.7 Russia Parkinsons Disease Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Parkinsons Disease Drugs Market Size, 2017-2028
6.5.9 Benelux Parkinsons Disease Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Parkinsons Disease Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Parkinsons Disease Drugs Sales, 2017-2028
6.6.3 China Parkinsons Disease Drugs Market Size, 2017-2028
6.6.4 Japan Parkinsons Disease Drugs Market Size, 2017-2028
6.6.5 South Korea Parkinsons Disease Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Parkinsons Disease Drugs Market Size, 2017-2028
6.6.7 India Parkinsons Disease Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Parkinsons Disease Drugs Revenue, 2017-2028
6.7.2 By Country - South America Parkinsons Disease Drugs Sales, 2017-2028
6.7.3 Brazil Parkinsons Disease Drugs Market Size, 2017-2028
6.7.4 Argentina Parkinsons Disease Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Parkinsons Disease Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Parkinsons Disease Drugs Sales, 2017-2028
6.8.3 Turkey Parkinsons Disease Drugs Market Size, 2017-2028
6.8.4 Israel Parkinsons Disease Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Parkinsons Disease Drugs Market Size, 2017-2028
6.8.6 UAE Parkinsons Disease Drugs Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Parkinsons Disease Drugs Major Product Offerings
7.1.4 Johnson & Johnson Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Johnson & Johnson Key News
7.2 Gilead Sciences
7.2.1 Gilead Sciences Corporate Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Parkinsons Disease Drugs Major Product Offerings
7.2.4 Gilead Sciences Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Gilead Sciences Key News
7.3 Pacira
7.3.1 Pacira Corporate Summary
7.3.2 Pacira Business Overview
7.3.3 Pacira Parkinsons Disease Drugs Major Product Offerings
7.3.4 Pacira Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Pacira Key News
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Corporate Summary
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Parkinsons Disease Drugs Major Product Offerings
7.4.4 Sun Pharmaceutical Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Sun Pharmaceutical Key News
7.5 Luye Pharma
7.5.1 Luye Pharma Corporate Summary
7.5.2 Luye Pharma Business Overview
7.5.3 Luye Pharma Parkinsons Disease Drugs Major Product Offerings
7.5.4 Luye Pharma Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Luye Pharma Key News
7.6 Sigma-Tau Group
7.6.1 Sigma-Tau Group Corporate Summary
7.6.2 Sigma-Tau Group Business Overview
7.6.3 Sigma-Tau Group Parkinsons Disease Drugs Major Product Offerings
7.6.4 Sigma-Tau Group Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Sigma-Tau Group Key News
7.7 Fudan-Zhangjiang
7.7.1 Fudan-Zhangjiang Corporate Summary
7.7.2 Fudan-Zhangjiang Business Overview
7.7.3 Fudan-Zhangjiang Parkinsons Disease Drugs Major Product Offerings
7.7.4 Fudan-Zhangjiang Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Fudan-Zhangjiang Key News
7.8 Teva Pharmaceutical
7.8.1 Teva Pharmaceutical Corporate Summary
7.8.2 Teva Pharmaceutical Business Overview
7.8.3 Teva Pharmaceutical Parkinsons Disease Drugs Major Product Offerings
7.8.4 Teva Pharmaceutical Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Teva Pharmaceutical Key News
7.9 CSPC
7.9.1 CSPC Corporate Summary
7.9.2 CSPC Business Overview
7.9.3 CSPC Parkinsons Disease Drugs Major Product Offerings
7.9.4 CSPC Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.9.5 CSPC Key News
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Parkinsons Disease Drugs Major Product Offerings
7.10.4 Novartis Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Novartis Key News
7.11 Kingond Pharm
7.11.1 Kingond Pharm Corporate Summary
7.11.2 Kingond Pharm Parkinsons Disease Drugs Business Overview
7.11.3 Kingond Pharm Parkinsons Disease Drugs Major Product Offerings
7.11.4 Kingond Pharm Parkinsons Disease Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Kingond Pharm Key News
8 GLOBAL PARKINSONS DISEASE DRUGS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Parkinsons Disease Drugs Production Capacity, 2017-2028
8.2 Parkinsons Disease Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Parkinsons Disease Drugs Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PARKINSONS DISEASE DRUGS SUPPLY CHAIN ANALYSIS
10.1 Parkinsons Disease Drugs Industry Value Chain
10.2 Parkinsons Disease Drugs Upstream Market
10.3 Parkinsons Disease Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Parkinsons Disease Drugs Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Parkinsons Disease Drugs in Global Market
Table 2. Top Parkinsons Disease Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Parkinsons Disease Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Parkinsons Disease Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Parkinsons Disease Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Parkinsons Disease Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Parkinsons Disease Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Parkinsons Disease Drugs Product Type
Table 9. List of Global Tier 1 Parkinsons Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Parkinsons Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Parkinsons Disease Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Parkinsons Disease Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Parkinsons Disease Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Parkinsons Disease Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Parkinsons Disease Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Parkinsons Disease Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Parkinsons Disease Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Parkinsons Disease Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Parkinsons Disease Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Parkinsons Disease Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Parkinsons Disease Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Parkinsons Disease Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Parkinsons Disease Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Parkinsons Disease Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Parkinsons Disease Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Parkinsons Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Parkinsons Disease Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Parkinsons Disease Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Parkinsons Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Parkinsons Disease Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Parkinsons Disease Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Parkinsons Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Parkinsons Disease Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Parkinsons Disease Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Parkinsons Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Parkinsons Disease Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Parkinsons Disease Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Parkinsons Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Parkinsons Disease Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Parkinsons Disease Drugs Sales, (K Units), 2023-2028
Table 46. Johnson & Johnson Corporate Summary
Table 47. Johnson & Johnson Parkinsons Disease Drugs Product Offerings
Table 48. Johnson & Johnson Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Gilead Sciences Corporate Summary
Table 50. Gilead Sciences Parkinsons Disease Drugs Product Offerings
Table 51. Gilead Sciences Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Pacira Corporate Summary
Table 53. Pacira Parkinsons Disease Drugs Product Offerings
Table 54. Pacira Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Sun Pharmaceutical Corporate Summary
Table 56. Sun Pharmaceutical Parkinsons Disease Drugs Product Offerings
Table 57. Sun Pharmaceutical Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Luye Pharma Corporate Summary
Table 59. Luye Pharma Parkinsons Disease Drugs Product Offerings
Table 60. Luye Pharma Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Sigma-Tau Group Corporate Summary
Table 62. Sigma-Tau Group Parkinsons Disease Drugs Product Offerings
Table 63. Sigma-Tau Group Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Fudan-Zhangjiang Corporate Summary
Table 65. Fudan-Zhangjiang Parkinsons Disease Drugs Product Offerings
Table 66. Fudan-Zhangjiang Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Teva Pharmaceutical Corporate Summary
Table 68. Teva Pharmaceutical Parkinsons Disease Drugs Product Offerings
Table 69. Teva Pharmaceutical Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. CSPC Corporate Summary
Table 71. CSPC Parkinsons Disease Drugs Product Offerings
Table 72. CSPC Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Novartis Corporate Summary
Table 74. Novartis Parkinsons Disease Drugs Product Offerings
Table 75. Novartis Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Kingond Pharm Corporate Summary
Table 77. Kingond Pharm Parkinsons Disease Drugs Product Offerings
Table 78. Kingond Pharm Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Parkinsons Disease Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 80. Global Parkinsons Disease Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Parkinsons Disease Drugs Production by Region, 2017-2022 (K Units)
Table 82. Global Parkinsons Disease Drugs Production by Region, 2023-2028 (K Units)
Table 83. Parkinsons Disease Drugs Market Opportunities & Trends in Global Market
Table 84. Parkinsons Disease Drugs Market Drivers in Global Market
Table 85. Parkinsons Disease Drugs Market Restraints in Global Market
Table 86. Parkinsons Disease Drugs Raw Materials
Table 87. Parkinsons Disease Drugs Raw Materials Suppliers in Global Market
Table 88. Typical Parkinsons Disease Drugs Downstream
Table 89. Parkinsons Disease Drugs Downstream Clients in Global Market
Table 90. Parkinsons Disease Drugs Distributors and Sales Agents in Global Market
Table 1. Key Players of Parkinsons Disease Drugs in Global Market
Table 2. Top Parkinsons Disease Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Parkinsons Disease Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Parkinsons Disease Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Parkinsons Disease Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Parkinsons Disease Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Parkinsons Disease Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Parkinsons Disease Drugs Product Type
Table 9. List of Global Tier 1 Parkinsons Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Parkinsons Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Parkinsons Disease Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Parkinsons Disease Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Parkinsons Disease Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Parkinsons Disease Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Parkinsons Disease Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Parkinsons Disease Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Parkinsons Disease Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Parkinsons Disease Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Parkinsons Disease Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Parkinsons Disease Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Parkinsons Disease Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Parkinsons Disease Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Parkinsons Disease Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Parkinsons Disease Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Parkinsons Disease Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Parkinsons Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Parkinsons Disease Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Parkinsons Disease Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Parkinsons Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Parkinsons Disease Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Parkinsons Disease Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Parkinsons Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Parkinsons Disease Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Parkinsons Disease Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Parkinsons Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Parkinsons Disease Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Parkinsons Disease Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Parkinsons Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Parkinsons Disease Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Parkinsons Disease Drugs Sales, (K Units), 2023-2028
Table 46. Johnson & Johnson Corporate Summary
Table 47. Johnson & Johnson Parkinsons Disease Drugs Product Offerings
Table 48. Johnson & Johnson Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Gilead Sciences Corporate Summary
Table 50. Gilead Sciences Parkinsons Disease Drugs Product Offerings
Table 51. Gilead Sciences Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Pacira Corporate Summary
Table 53. Pacira Parkinsons Disease Drugs Product Offerings
Table 54. Pacira Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Sun Pharmaceutical Corporate Summary
Table 56. Sun Pharmaceutical Parkinsons Disease Drugs Product Offerings
Table 57. Sun Pharmaceutical Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Luye Pharma Corporate Summary
Table 59. Luye Pharma Parkinsons Disease Drugs Product Offerings
Table 60. Luye Pharma Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Sigma-Tau Group Corporate Summary
Table 62. Sigma-Tau Group Parkinsons Disease Drugs Product Offerings
Table 63. Sigma-Tau Group Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Fudan-Zhangjiang Corporate Summary
Table 65. Fudan-Zhangjiang Parkinsons Disease Drugs Product Offerings
Table 66. Fudan-Zhangjiang Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Teva Pharmaceutical Corporate Summary
Table 68. Teva Pharmaceutical Parkinsons Disease Drugs Product Offerings
Table 69. Teva Pharmaceutical Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. CSPC Corporate Summary
Table 71. CSPC Parkinsons Disease Drugs Product Offerings
Table 72. CSPC Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Novartis Corporate Summary
Table 74. Novartis Parkinsons Disease Drugs Product Offerings
Table 75. Novartis Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Kingond Pharm Corporate Summary
Table 77. Kingond Pharm Parkinsons Disease Drugs Product Offerings
Table 78. Kingond Pharm Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Parkinsons Disease Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 80. Global Parkinsons Disease Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Parkinsons Disease Drugs Production by Region, 2017-2022 (K Units)
Table 82. Global Parkinsons Disease Drugs Production by Region, 2023-2028 (K Units)
Table 83. Parkinsons Disease Drugs Market Opportunities & Trends in Global Market
Table 84. Parkinsons Disease Drugs Market Drivers in Global Market
Table 85. Parkinsons Disease Drugs Market Restraints in Global Market
Table 86. Parkinsons Disease Drugs Raw Materials
Table 87. Parkinsons Disease Drugs Raw Materials Suppliers in Global Market
Table 88. Typical Parkinsons Disease Drugs Downstream
Table 89. Parkinsons Disease Drugs Downstream Clients in Global Market
Table 90. Parkinsons Disease Drugs Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Parkinsons Disease Drugs Segment by Type
Figure 2. Parkinsons Disease Drugs Segment by Application
Figure 3. Global Parkinsons Disease Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Parkinsons Disease Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Parkinsons Disease Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Parkinsons Disease Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Parkinsons Disease Drugs Revenue in 2021
Figure 9. By Type - Global Parkinsons Disease Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Parkinsons Disease Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Parkinsons Disease Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Parkinsons Disease Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Parkinsons Disease Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Parkinsons Disease Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Parkinsons Disease Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Parkinsons Disease Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Parkinsons Disease Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Parkinsons Disease Drugs Sales Market Share, 2017-2028
Figure 19. US Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Parkinsons Disease Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Parkinsons Disease Drugs Sales Market Share, 2017-2028
Figure 24. Germany Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Parkinsons Disease Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Parkinsons Disease Drugs Sales Market Share, 2017-2028
Figure 33. China Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Parkinsons Disease Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Parkinsons Disease Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Parkinsons Disease Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Parkinsons Disease Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Parkinsons Disease Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Parkinsons Disease Drugs by Region, 2021 VS 2028
Figure 50. Parkinsons Disease Drugs Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Parkinsons Disease Drugs Segment by Type
Figure 2. Parkinsons Disease Drugs Segment by Application
Figure 3. Global Parkinsons Disease Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Parkinsons Disease Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Parkinsons Disease Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Parkinsons Disease Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Parkinsons Disease Drugs Revenue in 2021
Figure 9. By Type - Global Parkinsons Disease Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Parkinsons Disease Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Parkinsons Disease Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Parkinsons Disease Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Parkinsons Disease Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Parkinsons Disease Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Parkinsons Disease Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Parkinsons Disease Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Parkinsons Disease Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Parkinsons Disease Drugs Sales Market Share, 2017-2028
Figure 19. US Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Parkinsons Disease Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Parkinsons Disease Drugs Sales Market Share, 2017-2028
Figure 24. Germany Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Parkinsons Disease Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Parkinsons Disease Drugs Sales Market Share, 2017-2028
Figure 33. China Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Parkinsons Disease Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Parkinsons Disease Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Parkinsons Disease Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Parkinsons Disease Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Parkinsons Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Parkinsons Disease Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Parkinsons Disease Drugs by Region, 2021 VS 2028
Figure 50. Parkinsons Disease Drugs Industry Value Chain
Figure 51. Marketing Channels
